Skip to main content
Clinical Trials/NCT02807090
NCT02807090
Completed
Not Applicable

Effect of Lumbar Stabilization Exercises and Circular Dances in Chronic Non Specific Low Back Pain in Middle-aged Women: Single-blind Randomized Clinical Trial

University of Sao Paulo General Hospital1 site in 1 country38 target enrollmentJune 2016
ConditionsLow Back Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain
Sponsor
University of Sao Paulo General Hospital
Enrollment
38
Locations
1
Primary Endpoint
Change in pain through Pain visual analogue scale
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Supervised exercises are the first line therapy for patients with chronic low back pain. The lumbar segmental stabilization (LSE) is a specific training for the muscles of the lumbar spine, which aims to improve neuromuscular control, strength and endurance of the muscles that promotes stability to the spine. The circular dance (CD) belongs to the group of complementary and integrative practices entered in Public Health Care in Brazil, and has been used to improve several aspects related to physical and mental states such as flexibility, posture, strength and muscular endurance, awareness or scheme body, pain control and strains. There are few studies evaluating the circular dance effect on back pain. The aim of this study is to compare the effects of lumbar stabilization exercises and circular dance for improvement in non specific low back pain in middle-aged women.

Detailed Description

OBJECTIVE: To compare the effect of CD with ESL exercises on pain and functional disability in women with nonspecific chronic low back pain (DLCI). METHOD: Thirty-eight women, aged 35-60 years, were randomly assigned to two groups: 1) Circular Dance group (gDC); 2) Lumbar Stabilization Exercise group (gESL). The primary clinical outcomes were pain, assessed using the Numerical Pain Scale and functional disability by the Roland Morris Disability Questionnaire and the secondary outcomes were: Depression assessed by the Beck Depression Inventory; Anxiety by the Numerical Anxiety Scale; Global Perception with the Global Effect Perception Scale, Signs and Symptoms of Adverse Effects analyzed by the Collective Subject Discourse and Quality of Life method using the Short-Form Health Survey Questionnaire (SF-36). The groups were treated twice a week for 60 minutes for 8 weeks totaling 16 sessions. Each participant was assessed before and after treatment and at follow-up 12 and 24 weeks.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
January 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnose of non specific low back pain for a period of three months without radiculopathy symptoms
  • Seek treatment

Exclusion Criteria

  • Inflammatory disorders of the spine
  • Spinal tumors
  • Spine surgery
  • Unconsolidated fractures or malunion of the spine
  • Rheumatologic disease
  • Spondylolysis or spondylolisthesis
  • Patients who are in labor dispute
  • Patients undergoing physical therapy or drug treatment to opioid-based

Outcomes

Primary Outcomes

Change in pain through Pain visual analogue scale

Time Frame: Before the treatment and after the treatment (immediately after the treatment, and 4 and 16 weeks after treatment) and in every session (from the first session to the sixteen session), immediately after session

Scale with 11 centimeters is used for evaluate pain intensity

Secondary Outcomes

  • Roland Morris Disability Questionnaire(Before and after the treatment (immediately after the treatment, and 4 and 16 weeks after treatment))
  • Global Perceived Effect Scale(Before and after the treatment (immediately after the treatment, and 4 and 16 weeks after treatment))
  • Visual analogue scale for anxiety(Before and after the treatment (immediately after the treatment, and 4 and 16 weeks after treatment))
  • Beck Depression Inventory(Before and after the treatment (immediately after the treatment, and 4 and 16 weeks after treatment))
  • Medical Outcomes Study 36 - Item Short - Form Health Survey(Before and after the treatment (immediately after the treatment, and 4 and 16 weeks after treatment))
  • Symptoms and Adverse events or side effects(Before and after the treatment (immediately after the treatment, and 4 and 16 weeks after treatment))

Study Sites (1)

Loading locations...

Similar Trials